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Abstract
Background: The current study aims to evaluate the association between neck circumference (NC) and several
cardio-metabolic risk factors, to compare it with well-established anthropometric indices, and to determine the
cut-off point value of NC for predicting children at increased risk of metabolic syndrome, insulin resistance and
low-grade systemic inflammation.
Methods: A total of 669 school children, aged 8–14, were recruited. Demographic, clinical, anthropometric and
biochemical data from all patients were collected. Correlations between cardio-metabolic risk factors and NC and
other anthropometric variables were evaluated using the Spearman’s correlation coefficient. Multiple linear regression
analysis was applied to further examine these associations. We then determined by receiver operating characteristic
(ROC) analyses the optimal cut-off for NC for identifying children with elevated cardio-metabolic risk.
Results: NC was positively associated with fasting plasma glucose and triglycerides (p = 0.001 for all), and systolic and
diastolic blood pressure, C-reactive protein, insulin and HOMA-IR (p < 0.001 for all), and negatively with HDL-C (p = 0.001).
Whereas, other anthropometric indices were associated with fewer risk factors.
Conclusions: NC could be used as clinically relevant and easy to implement indicator of cardio-metabolic risk in children.
Keywords: Childhood obesity, Anthropometric measurements, Neck circumference, Metabolic syndrome, Low-grade
systemic inflammation, Insulin resistance, Cardiometabolic risk, Latin America, Colombia
Background
The prevalence of obesity in children and adolescents is
increasing worldwide and it is now recognized as an
international public health concern [1]. Epidemiological
and clinical investigations have revealed that the associ-
ation between obesity and cardiovascular and metabolic
risk factors begins early in life [2, 3]. Childhood obesity
is associated with increased prevalence of hypertension,
dyslipidemia, and abnormal glucose tolerance [2–4].
Thus, identifying and controlling childhood obesity is an
important goal in the prevention of cardiovascular
diseases (CVD) in later life [5].
Although obesity is at the core of the development of
CVD, appropriate anthropometric measures and cut-off
points to identify children with elevated cardio-metabolic
risk factors are not well established. The most widely used
method to categorize overweight and obese children and to
predict cardiovascular and metabolic risk is the body mass
index (BMI) [6]. However, BMI has been considered as an
imperfect measure of adiposity, because it does not distin-
guish between muscle mass and fat mass, and requires
calculations and the use of charts that may not always be
available [7, 8].
Alternative measures to BMI such as waist-to-hip ratio
(WHR) and waist circumference, which also give some
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indication of fat distribution, have been used as alterna-
tives, but none of these have been accepted as a gold
standard measure to identify cardiovascular and meta-
bolic risk [9, 10]. Both have limitations in distinguishing
the contribution from ectopic adipose tissue and sub-
cutaneous adipose tissue [11], which show strong and
modest correlations to cardio-metabolic risk, respect-
ively [12, 13].
Prior studies have suggested that upper body fat
plays a role in cardio-metabolic risk [14, 15], and neck
circumference (NC) was proposed as a new measure-
ment to evaluate overweight and obesity in children
[16–18]. NC has demonstrated to be an independent
predictor of metabolic risk beyond BMI and waist cir-
cumference [15] and to be positively associated with
insulin resistance and visceral adipose tissue in adults
[19], but few studies have been conducted to deter-
mine its association with cardio-metabolic risk factors
in children [20, 21]. Hence, the aims of the present
study were to evaluate the association between NC
and several cardio-metabolic risk factors and to compare
these associations with those of BMI and other well-




During the 2011–2012 school year, we conducted the
cross-sectional component of the ACFIES study (Associ-
ation between Cardiorespiratory Fitness, Muscular Strength
and Body Composition with Metabolic Risk Factors
in Colombian Children) to identify the prevalence
and associations of cardiovascular risk factors, in a sample
of schoolchildren from both sexes, enrolled in public
elementary and high schools (grades 5 and 6), from the
city of Bucaramanga, Colombia. All the recruited partici-
pants met the general ACFIES inclusion criteria: age range
8 to 14 years, not having any physical disability and be free
of any acute infection lasting less than 2 weeks before the
inclusion. Moreover, children were excluded if were using
medications that could alter blood pressure, insulin resist-
ance, glycemic levels and/or lipid profile. The study proto-
col was in accordance with the Declaration of Helsinki
and was approved by the Health Research Ethics Board of
the Ophthalmological Foundation of Santander (FOS-
CAL). The children expressed their interest in partici-
pating in the study, and parents or legal guardians gave
written informed consent, before the children were
included in the study.
Anthropometric measurements and physical examination
All physical assessments and anthropometric measure-
ments were performed after an overnight fast (8 to 10 h), in
duplicate by well-trained health workers. For the analysis
we used the mean of the two measurements. Participant’s
body weight was measured to the nearest 0.1 kg on an elec-
tronic device (Tanita BC544, Tokyo, Japan), in underwear
and without shoes, and height was measured to the nearest
0.1 cm using a mechanical stadiometer with platform (Seca
274, Hamburg, Germany), while participants were asked to
stand erect with their head positioned in the Frankfort
horizontal plane. BMI was calculated by dividing body
weight by the square of height (BMI = weight (kg)/
height (m)2). The weight status was classified accord-
ing to Barlow et al. [22].
Neck circumference was measured to the nearest
0.1 cm using a tape measure. The superior border of the
tape measure was placed just below the laryngeal prom-
inence and applied perpendicular to long axis of the
neck. Waist circumference was determined at the middle
point between the lower edge of the ribs and the iliac
anterior spine. The measurement was made at the end
of a normal expiration while the subject stood upright.
Hip circumference was measured over non-restrictive
underwear at the level of the maximum extension of the
buttocks posteriorly in a horizontal plane. All circumfer-
ences were measured using a measuring tape with spring
scale (Ohaus 8004-MA, NJ, USA). WHR was calculated
as waist circumference divided by hip circumference.
Waist-to-height ratio (WHtR) was calculated by dividing
waist circumference by height in cm. The measurements
were realized according to the procedures previously de-
scribed by Lohman et al. [23].
Skinfold thickness was measured to the nearest 0.2 mm
on the right side of the body at the triceps and subscapular
sites using a skinfold caliper (Harpenden C-136, United
Kingdom) and body fat percentage (%BF-Skinfold) esti-
mated using skinfold equations described by Slaughter et al
[24]. Body fat percentage was also assessed by bioelectrical
impedance analysis (BIA) (%BF-BIA) (Tanita BC544, Tokyo,
Japan). Systolic blood pressure and diastolic blood pressure
were determined after a resting period of 10 min in the
sitting position using an automatic and calibrated sphygmo-
manometer with a pediatric cuff (Omron HEM 757 CAN,
Hoofddorp, Netherlands). Pubertal development was
assessed by Tanner stage of breast development in girls and
testicular volume in boys [25].
Biochemical parameters
Venous blood samples were collected in the morning at
the same time (07:00 am to 09:00 am), after an overnight
fast (8 to 10 h), and from the antecubital vein. Participants
were asked not to do any prolonged exercise during the
24 h prior to the exam. Blood samples were analyzed for
concentrations of fasting plasma glucose and lipid profile
(total cholesterol, triglycerides, and high-density lipo-
protein cholesterol (HDL-C)) using a routine colorimetric
method (Biosystems BTS-303 Photometric, Barcelona,
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Spain). High-sensitivity C-reactive protein (hs-CRP) was
quantified using a turbid metric test (SPINREACT, Spain),
and insulin levels were determined using an insulin mi-
croplate ELISA test (Monobind, USA). Samples were
processed and analyzed in the clinical laboratory of bac-
teriology school of the University of Santander - UDES.
Homeostasis model assessment for insulin resistance
(HOMA-IR) was calculated using the equation: HOMA-
IR = Fasting insulin (lU/ml) x Fasting glucose (mg/dl)/
405 [26].
Cardiovascular and metabolic risk definition
For this study, the cardiovascular and metabolic risk in chil-
dren and adolescents was defined according to a modified
version of the National Health and Nutrition Examination
Survey (NHANES) definition of metabolic syndrome
(MetS) [27]. The considered parameters were: increased
waist circumference (≥75th percentile for age and sex of
study cohort), elevated triglycerides (≥110 mg/dl), low
HDL-C (≤40 mg/dl), elevated systolic blood pressure and/
or diastolic blood pressure (≥90 percentile for age, sex and
height), and elevated fasting plasma glucose (≥100 mg/dl).
MetS was defined by the presence of 3 or more of the
above criteria [27]. Although the NHANES definition was
not intended to be applied to children below 12 years of
age, for the purposes of this study to enable comparisons to
be made and as cardiovascular and metabolic alterations
can be present in children from their earliest years of
life [2, 3], we have defined the individual risk compo-
nents of MetS across the complete sample of children
aged between 8 to 14 years. Moreover, a value of ≥2.6 in
HOMA-IR was considered to indicate insulin resistance
[28], and values of hs-CRP ≥0.55 mg/dl (75th percentile in
our study sample) were considered as low-grade systemic
inflammation.
Statistical analysis
Descriptive statistics were computed for variables of
interest, and included mean values and standard
deviations of continuous variables and absolute and
relative frequencies of categorical factors. Normality
of distribution was checked for continuous variables using
the Shapiro-Wilk test and by graphical methods.
Student’s t-test and Mann-Whitney test were used to
assess potential differences in continuous variables. We
tested for differences in categorical variables using the
Pearson’s chi-squared test (Chi2). Correlations between
cardio-metabolic risk factors and anthropometric vari-
ables were evaluated using the Pearson’s correlation or
Spearman’s correlation coefficient, according to normality of
distributions. Multiple linear regression analysis was applied
to further examine these associations.
For selection of the cut-off points of NC that could
identify MetS, insulin resistance and low-grade systemic
inflammation according to gender, analyzes were made
using the ROC (receiver operating characteristic) curves.
The statistical significance of each analysis was verified
by the area under the ROC curve (AUCs) and by 95 %
confidence intervals (95 % CI´s). The maximum values
of the Youden’s index [29] were used as a criterion for
selecting the optimum cut-off points. All statistical
analyzes were carried out using Stata statistical soft-
ware, release 11.0 (Stata Corporation, College Station,
TX, USA). A p < 0.05 was considered statistically significant.
Results
Descriptive statistics
As it has been previously reported [30, 31], a total of 669
children and adolescents were recruited during the cross-
sectional component of the ACFIES study, of which 351
(52.5 %) were boys. The overall mean age was 11.5 ±
1.1 years. Demographic, anthropometric and metabolic
characteristics of the study population by sex are presented
in Table 1. Compared to the girls, mean systolic blood pres-
sure, waist circumference, WHR, WHtR, NC and %BF-
Skinfold were significantly higher, while height, %BF-BIA,
triglycerides, insulin and HOMA-IR were significantly
lower in boys. Among our study population, 85 (12.9 %)
were overweight and 65 (9.8 %) were obese. There were no
statistically significant differences in weight status and BMI
between both genders. Sex-specific prevalences of MetS
and its individual abnormalities, insulin resistance and low-
grade systemic inflammation were also estimated (Fig. 1),
and statistical differences were not found.
Correlation between anthropometric indexes and
cardio-metabolic risk factors
Correlations of anthropometric indexes and cardio-
metabolic risk factors are presented in Table 2 for the total
sample and by gender. Z-score BMI was positively corre-
lated with triglycerides, systolic and diastolic blood pres-
sure, hs-CRP, insulin and HOMA-IR in both genders, and
inversely correlated with HDL-C only in boys. Z-score WC
was positively correlated with triglycerides, systolic and dia-
stolic blood pressure, insulin and HOMA-IR in both gen-
ders, with fasting plasma glucose and hs-CRP only in girls,
and inversely correlated with HDL-C only in boys. WHR
was positively correlated only with triglycerides in both
genders, with diastolic blood pressure, insulin and HOMA-
IR only in boys, and with hs-CRP only in girls. WHtR was
positively correlated with triglycerides, systolic and diastolic
blood pressure, insulin and HOMA-IR in both genders,
and with hs-CRP only in girls. %BF-BIA was positively
correlated with triglycerides, systolic and diastolic blood
pressure, insulin and HOMA-IR in both genders, with hs-
CRP only in girls, and inversely correlated with HDL-C
only in girls. %BF-Skinfold was positively correlated with
systolic and diastolic blood pressure, hs-CRP, insulin and
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HOMA-IR in both genders, with triglycerides only in
boys, and inversely correlated with HDL-C in both
genders. NC was positively correlated with fasting
plasma glucose, systolic and diastolic blood pressure,
hs-CRP, insulin and HOMA-IR in both genders, with
triglycerides only in boys, and inversely correlated with
HDL-C in both genders.
Multiple linear regression analysis between
anthropometric indexes and cardio-metabolic risk factors
Table 3 illustrates the results of the multivariate regres-
sion analysis conducted using separately each CVD risk
factor as the dependent variable and controlling for
age, gender and Tanner stage. Fating plasma glucose
was significantly associated only with NC, and HDL-C







Age (years)a 11.52 ± 1.13 11.52 ± 1.10 11.51 ± 1.16
SBP (mmHg)a 114.51 ± 11.59 113.29 ± 11.72 115.58 ± 11.38b
DBP (mmHg)a 73.78 ± 9.47 73.66 ± 8.97 73.86 ± 9.93
Anthropometric measuresa
Weight (kg) 40.08 ± 10.07 40.33 ± 9.77 39.86 ± 10.35
Height (m) 1.45 ± 0.09 1.45 ± 0.08 1.44 ± 0.09b
BMI (kg/m2) 18.87 ± 3.61 18.81 ± 3.52 18.93 ± 3.68
WC (cm) 65.95 ± 9.73 64.86 ± 9.02 66.92 ± 10.24b
WHR 0.84 ± 0.08 0.81 ± 0.06 0.86 ± 0.09b
WHtR 0.45 ± 0.06 0.44 ± 0.06 0.46 ± 0.06b
NC (cm) 29.93 ± 2.39 28.40 ± 2.06 29.41 ± 2.55b
%BF-BIA 20.47 ± 7.50 22.71 ± 6.89 18.43 ± 7.46b
%BF-Skinfold 25.47 ± 11.37 24.63 ± 9.10 26.23 ± 13.04b
Z-score BMI (kg/m2) -0.0004 ± 0.98 -0.0008 ± 0.98 -5.45-7 ± 0.98
Z-score WC (cm) -0.038 ± 0.99 4.88-8 ± 0.99 -0.073 ± 0.99b
Biochemical measurementsa
FPG (mg/dl) 88.52 ± 12.56 87.87 ± 12.32 89.12 ± 12.76
TC (mg/dl) 159.23 ± 39.28 158.25 ± 39.04 160.13 ± 39.53
HDL-C (mg/dl) 75.34 ± 19.96 74.57 ± 19.82 76.04 ± 20.08
TG (mg/dl) 91.76 ± 52.37 94.07 ± 46.79 89.67 ± 56.97b
hs-CRP (mg/dl) 0.89 ± 1.62 0.88 ± 1.52 0.89 ± 1.71
Insulin (lU/ml) 2.58 ± 2.61 2.91 ± 2.91 2.29 ± 2.26b
HOMA-IR 0.57 ± 0.58 0.64 ± 0.66 0.50 ± 0.50b
Weight status (n - %)d
o Underweight 29 (4.4) 9 (2.9) 20 (5.8)
o Normal weight 479 (72.8) 240 (77.2) 239 (68.9)
o Overweight 85 (12.9) 42 (13.5) 43 (12.4)
o Obese 65 (9.8) 20 (6.4) 45 (12.9)
Tanner stage (n - %)e
o 1 368 (56.3) 149 (47.8) 219 (64.0)c
o 2 208 (31.8) 110 (35.3) 98 (28.7)
o 3 78 (11.9) 53 (16.9) 25 (7.3)
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-height ratio,
NC neck circumference, %BF-BIA body fat percentage – bioelectrical impedance analysis, %BF-Skinfold body fat percentage – skinfolds, FPG fasting plasma glucose,
TC total cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, hs-CRP high sensitivity C-reactive protein
aData are presented as mean ± standard deviation for continuous variables. bMann-Whitney test p < 0.05. cPearson’s chi-squared test (Chi2) p <0.05
ddata missing for 11 participants
edata missing for 15 participants
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was associated with waist circumference and NC. In
contrast, triglycerides, hs-CRP, insulin and HOMA-IR
were significantly associated with all the anthropomet-
ric indices, whereas systolic and diastolic blood pres-
sures were associated with all the anthropometric
indices, except WHR.
Neck circumference cut-off points to identify MetS, insulin
resistance and low-grade systemic inflammation according
to gender
The cut-off points and respective sensitivity and specificity
values, the AUCs and the Youden’s index of NC for the
identification of MetS, insulin resistance and low-grade
Fig. 1 Prevalence of metabolic syndrome and its components, insulin resistance and low-grade systemic inflammation among study population.
Data are presented as relative frequencies with 95 % confidence intervals represented by vertical bars. Significant differences between girls and
boys (Pearson’s chi-squared test (Chi2)). FPG: fasting plasma glucose; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; SBP: systolic
blood pressure; DBP: diastolic blood pressure; WC: waist circumference; hs-CRP: high sensitivity C-reactive protein
Table 2 Correlations between cardiometabolic risk factors and anthropometric measurements according to gender
Z-score BMI Z-score WC Waist to hip ratio Waist to height ratio
Total Girls Boys Total Girls Boys Total Girls Boys Total Girls Boys
FPG (mg/dl) 0.08 0.10 0.06 0.10* 0.13* 0.08 -0.04 -0.08 -0.07 0.02 0.01 0.02
HDL-C (mg/dl) -0.12* -0.09 -0.15* -0.16** -0.10 -0.21** 0.02 0.01 -0.02 -0.06 -0.08 -0.07
TG (mg/dl) 0.16** 0.15* 0.17* 0.23** 0.19* 0.25** 0.10* 0.12* 0.20** 0.15** 0.15* 0.19**
SBP (mmHg) 0.29** 0.28** 0.30** 0.31** 0.31** 0.33** 0.08* 0.01 0.04 0.21** 0.17* 0.21**
DBP (mmHg) 0.35** 0.36** 0.33** 0.35** 0.33** 0.37** 0.06 -0.03 0.17* 0.29** 0.26** 0.33**
hs-CRP (mg/dl) 0.15* 0.19* 0.12* 0.15** 0.21** 0.09 0.04 0.12* 0.01 0.14** 0.22** 0.08
Insulin (Ul/ml) 0.27** 0.28** 0.27** 0.29** 0.23** 0.33** 0.06 0.06 0.23** 0.24** 0.21** 0.34**
HOMA-IR 0.27** 0.27** 0.26** 0.29** 0.24** 0.33** 0.05 0.03 0.21** 0.24** 0.20* 0.33**
%BF – BIA %BF - Skinfold Neck Circumference
Total Girls Boys Total Girls Boys Total Girls Boys
FPG (mg/dl) 0.01 0.09 -0.03 0.06 0.10 0.04 0.20** 0.19** 0.19**
HDL-C (mg/dl) -0.09* -0.12* -0.02 -0.12* -0.11* -0.13* -0.19** -0.12* -0.29**
TG (mg/dl) 0.18** 0.13* 0.17* 0.15** 0.09 0.19** 0.11* 0.10 0.18*
SBP (mg/dl) 0.17** 0.26** 0.20** 0.24** 0.25** 0.23** 0.39** 0.34** 0.42**
DBP (mg/dl) 0.33** 0.39** 0.32** 0.35** 0.41** 0.30** 0.29** 0.29** 0.31**
hs-CRP (mg/dl) 0.11* 0.18* 0.05 0.16** 0.18* 0.15* 0.15** 0.17* 0.15*
Insulin (Ul/ml) 0.30** 0.24** 0.29** 0.28** 0.21** 0.33** 0.19** 0.22** 0.25**
HOMA-IR 0.28** 0.24** 0.27** 0.28** 0.23** 0.32** 0.21** 0.23** 0.27**
*Spearman’s correlation coefficient p < 0.05. **Spearman’s correlation coefficient p < 0.001
BMI body mass index, WC waist circumference, %BF-BIA body fat percentage – bioelectrical impedance analysis, %BF-Skinfold body fat percentage – skinfolds, FPG
fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, hs-CRP high sensitivity
C-reactive protein
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systemic inflammation according to gender are shown in
Table 4. NC cut-off values for MetS were calculated to be
28.5 cm (95 % CI, 0.68 – 0.78) in girls and 29 cm (95 %
CI, 0.68 – 0.78) in boys, 29.3 cm (95 % CI, 0.49 – 0.60) in
girls and 29.2 (95 % CI, 0.47 – 0.58) in boys for detecting
low-grade systemic inflammation, and 29 cm (95 % CI,
0.51 – 0.62) in girls and 30 cm (95 % CI, 0.49 – 0.59) in
boys for identifying insulin resistance (Table 5).
Discussion
We found that NC was associated with all the assessed
cardio-metabolic risk factors similar to that observed for
waist circumference, which was associated with all the
cardio-metabolic risk factors except fasting plasma glucose.
The association for HDL-C was more robust for NC than
for waist circumference. The other anthropometric indices
were not associated neither with fasting plasma glucose nor
HDL-C, and WHR was also not associated with systolic
and diastolic blood pressure. Interestingly, similar NC cut-
off points for identifying children at elevated risk of MetS,
insulin resistance and low-grade systemic inflammation
were obtained by gender (28.5 to 29.3 cm in girls and 29 to
30 cm in boys), making it a simple marker of metabolic
risk. Therefore, NC is a measure that potentially might be
implemented in situations where equipment availability or
cultural issues limit the use of the traditional anthropomet-
ric measures.
Moreover, it should be noted that in cases wherein sig-
nificant associations were found, most of the anthropomet-
ric measures were similar to each other in the strength of
Table 3 Multiple linear regression analysis, using each cardiometabolic risk factor as the dependent variable
Dependent variable Independent factor Coef. ± SE P Value Dependent variable Independent factor Coef. ± SE P Value
FPG (mg/dl) BMI (kg/m2) 0.193 ± 0.149 0.194 DBP (mmHg) BMI (kg/m2) 0.849 ± 0.106 <0.001
WC (cm) 0.100 ± 0.056 0.075 WC (cm) 0.346 ± 0.039 <0.001
WHR -12.777 ± 6.791 0.060 WHR 7.498 ± 5.024 0.136
WHtR 2.198 ± 8.620 0.799 WHtR 46.847 ± 6.094 <0.001
%BF-BIA 0.063 ± 0.075 0.399 %BF-BIA 0.500 ± 0.051 <0.001
%BF-Skinfold 0.039 ± 0.045 0.393 %BF-Skinfold 0.283 ± 0.031 <0.001
NC (cm) 0.815 ± 0.244 0.001 NC (cm) 1.305 ± 0.173 <0.001
HDL-C (mg/dl) BMI (kg/m2) -0.279 ± 0.236 0.237 hs-CRP (mg/dl) BMI (kg/m2) 0.132 ± 0.020 <0.001
WC (cm) -0.237 ± 0.088 0.008 WC (cm) 0.043 ± 0.007 <0.001
WHR -6.135 ± 10.745 0.568 WHR 2.459 ± 0.936 0.009
WHtR -21.145 ± 13.584 0.120 WHtR 7.225 ± 1.177 <0.001
%BF-BIA -0.149 ± 0.116 0.203 %BF-BIA 0.061 ± 0.010 <0.001
%BF-Skinfold -0.133 ± 0.072 0.067 %BF-Skinfold 0.037 ± 0.006 <0.001
NC (cm) -1.333 ± 0.384 0.001 NC (cm) 0.133 ± 0.034 <0.001
TG (mg/dl) BMI (kg/m2) 2.149 ± 0.621 0.001 Insulin (Ul/ml) BMI (kg/m2) 0.245 ± 0.031 <0.001
WC (cm) 1.253 ± 0.229 <0.001 WC (cm) 0.108 ± 0.011 <0.001
WHR 104.268 ± 28.023 <0.001 WHR 5.850 ± 1.448 <0.001
WHtR 155.901 ± 35.351 <0.001 WHtR 14.963 ± 1.785 <0.001
%BF-BIA 1.260 ± 0.313 <0.001 %BF-BIA 0.130 ± 0.015 <0.001
%BF-Skinfold 0.754 ± 0.190 <0.001 %BF-Skinfold 0.086 ± 0.009 <0.001
NC (cm) 3.887 ± 1.014 <0.001 NC (cm) 0.362 ± 0.051 <0.001
SBP (mmHg) BMI (kg/m2) 0.705 ± 0.129 <0.001 HOMA-IR BMI (kg/m2) 0.055 ± 0.007 <0.001
WC (cm) 0.311 ± 0.048 <0.001 WC (cm) 0.024 ± 0.002 <0.001
WHR 7.001 ± 6.020 0.245 WHR 1.192 ± 0.330 <0.001
WHtR 34.576 ± 7.503 <0.001 WHtR 3.306 ± 0.407 <0.001
%BF-BIA 0.362 ± 0.064 <0.001 %BF-BIA 0.029 ± 0.003 <0.001
%BF-Skinfold 0.206 ± 0.039 <0.001 %BF-Skinfold 0.018 ± 0.002 <0.001
NC (cm) 1.719 ± 0.205 <0.001 NC (cm) 0.085 ± 0.011 <0.001
After controlling for age, gender and Tanner stage
FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, hs-CRP high sensitivity
C-reactive protein, BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-height ratio, %BF-BIA body fat percentage – bioelectrical impedance
analysis, %BF-Skinfold body fat percentage – skinfolds, NC neck circumference
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these associations. Thus, our results confirm the value of a
complete anthropometric assessment in the identification
of cardiovascular and metabolic risk factors in children.
Adiposity is widely accepted to play a key role in the
pathogenesis of cardiovascular and metabolic diseases in
children [3–5, 32]. So, it is important the identification
of overweight children with cardio-metabolic risk factors
in whom counseling and treatment must be provided in
a timely manner. The determination of biochemical vari-
ables is costly, making impractical its use as a screening
tool, particularly in low-middle income countries with
lower resources. Thus, the present findings showing that
NC, which only requires a tape measure, is effective,
simple, easy-to-use and inexpensive anthropometric
measurement to identify children and adolescents with
cardio-metabolic risk constitute an important contribu-
tion from a public health perspective.
However, previous studies [20, 21] have assessed the
association between NC and cardio-metabolic risk in
children, our study has the strength of having the largest
pediatric population sample to date. Moreover, the re-
sults showed for the first time, an association between
high NC and abnormal values of fasting plasma glucose
and low-grade systemic inflammation. These results sup-
port the proposal of an increased cardio-metabolic risk
in our population at lower levels of adiposity [33–35].
Although NC is an emerging marker of cardio-metabolic
risk in children, it has been demonstrated as a good pre-
dictor of cardiovascular disease in adults with different con-
ditions such as MetS, obstructive sleep apnea and fatty liver
disease [15, 19, 36–39].
BMI has been the accepted standard measure of over-
weight and obesity for children two years of age and older
[40]. However, some studies have suggested that BMI is
not a good indicator of cardio-metabolic risk [7, 8, 41]. In
our current study BMI was associated with most of the
cardio-metabolic risk factors assessed, confirming that
despite its apparent limitations, in children BMI is non in-
ferior to measures that assess body composition and dif-
ferentiate fat and lean mass, such as BIA or skinfolds [42].
We found that associations between BIA and skinfolds
and cardio-metabolic risk factors were similar to that of
the anthropometric indices; but, in contrast to NC, neither
of these measures was associated with fasting plasma glu-
cose and HDL-C. Moreover, it is notable that despite
identical statistical associations with cardio-metabolic risk
of these two field measures of body composition, the
mean values were lower for BIA in boys and girls and
%BF-BIA was significantly higher in girls than boys, while
the reverse was the case for %BF-Skinfolds. Therefore, it is
not clear which of these two estimates of %BF is more
accurate or whether it is appropriate to calculate them
using predictive equations validated in different populations.
Fat distribution is also recognized as an important de-
terminant of metabolic risk [43] and those anthropomet-
ric measures such as waist circumference, WHR and
WHtR are good indicators of visceral adipose tissue and
therefore good predictors of cardiovascular risk [44–46].
Table 4 Neck circumference cut-offs points to identify metabolic syndrome, low-grade systemic inflammation and insulin resistance
in study sample according to gender
Cutoffs (cm) Sensitivity (%) Specificity (%) AUC (IC 95 %) Youden’s index
Metabolic Syndrome
Girls 28.5 87.50 53.61 0.73 (0.68 - 0.78) 0.41
Boys 29 100 45.37 0.74 (0.68 - 0.78) 0.45
Low-grade systemic inflammation
Girls 29.3 42.02 69.15 0.55 (0.49 - 0.60) 0.11
Boys 29.2 54.62 51.63 0.53 (0.47 - 0.58) 0.06
Insulin resistance
Girls 29 50.00 62.35 0.57 (0.51 - 0.62) 0.12
Boys 30 52.54 61.19 0.54 (0.49 - 0.59) 0.13
Receiver operating characteristic (ROC) analyzes. Youden’s index = Sensitivity + Specificity – 1
Table 5 Advantages and limitations in pediatric population of
anthropometrics measurements to identify metabolic alterations
FPG HDL-C TG SPB/DPB hs-CRP Insulin HOMA-IR
BMI - + ++ ++ ++ ++ ++
WC + + ++ ++ ++ ++ ++
WHR - - ++ + + + +
WHtR - - ++ ++ + ++ ++
%BF-BIA - + ++ ++ + ++ ++
%BF-Skinfold - ++ + ++ ++ ++ ++
NC ++ ++ + ++ ++ ++ ++
(-) Not correlation; (+) Correlation in girls or boys; (++) Correlation in both girls
and boys
FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, TG
triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, hs-CRP
high sensitivity C-reactive protein, BMI body mass index, WC waist circumference,
WHR waist-to-hip ratio, WHtR waist-to-height ratio, %BF-BIA body fat percentage –
bioelectrical impedance analysis, %BF-Skinfold body fat percentage – skinfolds,
NC neck circumference
Gomez-Arbelaez et al. BMC Pediatrics  (2016) 16:31 Page 7 of 9
In the present study, all these anthropometric indexes
showed acceptable correlations with the cardio-metabolic
risk factors, although none were superior to NC. Hence,
in agreement with previous studies, we can also suggest
the use of waist circumference, WHR and WHtR as an
optional adiposity indexes in relation to the cardiovascular
and metabolic health risk.
Our study should be interpreted in light of its limitations.
First, is a cross-sectional study; therefore, the association
with cardiovascular and metabolic disease outcomes could
not be established. Second, as pubertal growth and develop-
ment is characterized by changes in metabolic traits that
characterize the MetS [47], we suggest further studies with
larger sample sizes, in which the cut-off points would be
defined by pubertal development. Third, we defined the
cardio-metabolic risk using a modified NHANES definition
of MetS, which we considered as the most applicable in the
clinical practice based on the simplicity of its diagnostic cri-
teria, however it should be mentioned that the appropriate
risk factor cut-offs for children remain controversial, and
therefore further studies to define thresholds for abnormal-
ities of the metabolic components should be conducted.
Fourth, our study was specifically conducted in a pediatric
Latin American population. It has been proposed that fetal
programming associated to maternal undernutrition, which
prevalence still is high in Latin America, could affect the
body composition and the utility of different anthropomet-
rics measurements [35]. Hence, we believe that additional
studies should be performed testing whether the proposed
cut-offs points for NC are truly applicable in other popula-
tions and regions of the world.
Conclusions
We evaluated the association between several cardio-
metabolic risk factors and NC, a novel marker of risk,
and compared this with classic anthropometric measures
and indexes such as BMI and WHR and with field mea-
sures of body composition. While all of the anthropo-
metric measures and indexes we assessed showed some
associations with cardio-metabolic risk factors, including
insulin resistance and low-grade systemic inflammation,
we found that NC was the most consistent and robust
marker. Further longitudinal studies in representative
populations are required to confirm these findings and
to establish NC as a basic criterion in the diagnosis of
cardio-metabolic risk factors.
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